国产日本亚洲制服动漫,暖暖影院日本高清...免费,500黄色片在线观看

SNX-2112
產(chǎn)品描述：SNX-2112 is a potent synthetic heat shock protein 90(HSP90) inhibitor with an IC50 of 0.92 M for K562 cells.IC
2015-11-06 13:26 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1989.00/5mg
05mg起訂

PF-04929113
產(chǎn)品描述：PF-04929113 is a potent and selective Hsp90 inhibitor with an IC50 of median 50 nM.IC50 Value: 50 nMTarget: HS
2015-11-06 13:25 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1989.00/5mg
05mg起訂

BIIB021
產(chǎn)品描述：BIIB021(CNF2024) is an orally available, fully synthetic small-molecule inhibitor of HSP90 with Ki and EC50 of
2015-11-06 13:24 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

6026.00/100mg
0100mg起訂

17-AAG (Hydrochloride)
產(chǎn)品描述：17-AAG Hcl is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90
2015-11-06 13:22 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2744.00/100mg
0100mg起訂

17-AAG
產(chǎn)品描述：17-AAG(NSC 330507; CP 127374) is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding
2015-11-05 16:03 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2744.00/100mg
0100mg起訂

Retaspimycin (Hydrochloride)
產(chǎn)品描述：Retaspimycin Hcl(IPI504 Hcl) is the hydrochloride salt of a small-molecule inhibitor of heat shock protein 90
2015-11-05 16:02 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2558.00/10mg
010mg起訂

Masitinib (mesylate)
產(chǎn)品描述：Masitinib(AB-1010) mesylate is a novel inhibitor for Kit and PDGFR/ with IC50 of 200 nM and 540 nM/800 nM, wea
2015-11-05 16:00 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2898.00/100mg
0100mg起訂

Masitinib
產(chǎn)品描述：Masitinib(AB-1010) is a novel inhibitor for Kit and PDGFR/ with IC50 of 200 nM and 540 nM/800 nM, weak inhibit
2015-11-05 15:59 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

684.00/10mg
010mg起訂

Pazopanib
產(chǎn)品描述：Pazopanib(GW-786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms
2015-11-05 15:58 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1700.00/100mg
0100mg起訂

Amuvatinib
產(chǎn)品描述：Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFR and Flt3 with IC50 of 10 nM, 40 n
2015-11-05 15:57 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1548.00/5mg
05mg起訂

Cediranib
產(chǎn)品描述：Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of 1 nM, also inhibits Flt1/4 with IC50
2015-11-05 15:56 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1228.00/10mg
010mg起訂

OSI-930
產(chǎn)品描述：OSI-930 is a potent inhibitor of Kit, KDR and CSF-1R with IC50 of 80 nM, 9 nM and 15 nM, respectively; also po
2015-11-05 15:55 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1014.00/5mg
05mg起訂

Tandutinib
產(chǎn)品描述：Tandutinib (MLN518, CT53518) is a potent FLT3 antagonist with IC50 of 0.22 M, also inhibits PDGFR and c-Kit, 1
2015-11-05 15:54 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

884.00/100mg
0100mg起訂

Sorafenib (Tosylate)
產(chǎn)品描述：Sorafenib tosylate (BAY 43-9006) is a potent inhibitor of Raf-1 with IC50 values of 6 nM, 22 nM and 90 nM for
2015-11-05 15:53 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

600.00/100mg
0100mg起訂

Sorafenib
產(chǎn)品描述：Sorafenib(BAY 43-9006) is a potent inhibitor of Raf-1 with IC50 values of 6 nM, 22 nM and 90 nM for Raf-1, B-R
2015-11-05 15:52 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

600.00/100mg
0100mg起訂

BMS-754807
產(chǎn)品描述：BMS-754807 is a potent and reversible inhibitor of IGF-1R/InsR with IC50 of 1.8 nM/1.7 nM, less potent to Met,
2015-11-05 15:50 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1326.00/5mg
05mg起訂

SCH 527123
產(chǎn)品描述：SCH-527123 is a potent antagonist of both CXCR1 and CXCR2 with IC50 of 42 nM and 3 nM, respectively.IC50 value
2015-11-05 15:49 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2455.00/5mg
05mg起訂

YM-155 (hydrochloride)
產(chǎn)品描述：YM155 is a potent survivin suppressant by inhibiting Survivin promoter activity with IC50 of 0.54 nM.IC50 Valu
2015-11-05 15:48 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

515.00/5mg
05mg起訂

YM-155
產(chǎn)品描述：YM155 (Sepantronium bromide) is a novel small molecule survivin suppressant with an IC50 of 0.54 nM for the in
2015-11-05 15:45 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

515.00/5mg
05mg起訂

AZD-1480
產(chǎn)品描述：AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM, selectivity against JAK3 and Tyk2, and
2015-11-05 15:41 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]